| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
It has been a tough stretch for health-care stocks in 2019, and there is a good chance it isn’t over yet.[CR-LF][CR-LF]Sen. Bernie Sanders of Vermont is one of several Democratic presidential candidates pushing for Medicare for All. With the 2020 presidential election still 18 months away, the direction of health-care policy is likely to remain.[CR-LF][CR-LF]Quest Diagnostics (DGX) yields 2.2%. The company provides medical tests for a long list of medical conditions, including lung cancer, allergies, and hepatitis C. Last month it was named a preferred labor provider for UnitedHealth.
The reality of legalization in Illinois, if it happens at all, would likely be much hazier. Some employers might start turning a blind eye to employee use - as long as workers can still do their jobs - a trend that's already happening in some other states where it's legal. Other employers, however, might still ban its use, taking action against employees who test positive for pot, bolstered by federal law under which marijuana is still illegal, experts say. In Colorado, about 96 percent of employers who used the drug testing company Quest Diagnostics in 2017 still included marijuana in their employee drug testing, said Dr. Barry Sample, senior director of science and technology for Quest's employers solutions business. In Nevada, where recreational cannabis use is also legal, that number was 91 percent in 2017.
Recent surveys indicate that a majority of the nation's hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day. "Last December, a survey of hospital and health network C-level administrators conducted by Modern Healthcare and Quest Diagnostics revealed that nearly 80% of survey respondents were unaware that their institutions met the definition of 'applicable laboratory' and were thus legally required to report the clinical laboratory test prices they were paid by private health insurers," explained Robert L. Michel, Editor-In-Chief of THE DARK REPORT.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, received a perfect score of 100 from the Human Rights Campaign Foundation on the 2019 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBTQ Equality." The Corporate Equality Index (CEI) is a national benchmarking survey and report on corporate policies and practices related to LGBTQ workplace equality, administered by the Human Rights Campaign Foundation. This is third year Quest has earned the designation as a Best Place to Work for LGBTQ Equality.
Quest Diagnostics, the world's leading provider of diagnostic information services, hosted Massachusetts Governor Charlie Baker at its state-of-the-art clinical testing laboratory in Marlborough, Massachusetts on Friday, March 29. During the visit Governor Baker toured the laboratory, met with employees, and learned more about the company's initiatives in the areas of pricing transparency, Alzheimer's treatment and detection, and combatting the opioid epidemic. Marlborough Mayor Arthur Vigeant joined Governor Baker on the visit.
The prospect of marijuana legalization might inspire visions of weed-smoking breaks at work, or grabbing a joint with co-workers after a hectic day at the office.[CR-LF][CR-LF]But the reality of legalization in Illinois, if it happens at all, would likely be much hazier. Some employers might start turning a blind eye to employee use — as long as workers can still do their jobs — a trend that’s already happening in some other states where it’s legal. Other employers, however, might still ban its use, taking action against employees who test positive for pot, bolstered by federal law under which marijuana is still illegal, experts say. In Colorado, about 96 percent of employers who used the drug testing company Quest Diagnostics in 2017 still included marijuana in their employee drug testing, said Dr. Barry Sample, senior director of science and technology for Quest’s employers solutions business. In Nevada, where recreational cannabis use is also legal, that number was 91 percent in 2017.
Currently 10 states and Washington, D.C., allow recreational use of marijuana, and Illinois, New Jersey and New York are considering doing the same. This puts companies—already grappling with a shortage of workers—in a bind because an increasing number of candidates are failing routine drug tests due to smoking pot in those states, the Wall Street Journal reports. While legalized marijuana has created jobs and brought in additional tax dollars for those states, the spillover effect has more job applicants unable to pass standard drug tests, according to Quest Diagnostics.
In a perspective article in the New York Times, Dr. Diane M. Simeone, who directs the Pancreatic Cancer Center at New York University Langone Health, suggested that early detection is a solution. Quest Diagnostics found that 5.3 percent of retail workers tested positive for drugs in 2017, up from 4.7 percent in 2015, and the highest of any job sector. The Quest sampling suggests that about 837,000 of the 15.8 million retail workers across the U.S. would have tested positive if all had been checked.
An Arizona company has a new colon cancer blood test on the market that sounds like an enticing alternative to the oft-dreaded colonoscopy. The $170 blood test, called BeScreened-CRC, was developed by Phoenix-based diagnostics laboratory Beacon Biomedical and is a screening tool for colon cancer, its developer says. Sonora Quest Laboratories in Arizona has offered the test since December, and no doctor's order is required. It's not covered by Medicare. Coverage by commercial insurance plans varies.
Quest Diagnostics, the world's leading provider of diagnostic information services, announced today that it will present results of eight studies at the 2019 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, to be held April 2 – 6, 2019 in Seattle, Wash. (Quest Diagnostics booth 929). These studies by Quest Diagnostics researchers evaluate a broad range of laboratory technologies and best practices for aiding in the evaluation of risk for cancer and other diseases.
Last May, food services and facilities management company Sodexo fired a Massachusetts food supervisor after she tested positive for marijuana. It was standard policy—the employee, Bernadette Coughlin, had fallen at work, breaking her arm, and protocol required a mandatory drug test following an injury. Although Coughlin’s job was not “safety sensitive,” Sodexo’s policy was clear: One strike and you’re out. Quest Diagnostics, the medical testing company, has reported that five out of 16 industries—transportation and warehousing, retail trade, public administration, finance and insurance and wholesale trade—saw double-digit growth in positive drug tests between 2015 and 2017, with marijuana being the most commonly detected substance.
On Mar 22, we issued an updated research report on Quest Diagnostics, Inc. As a part of its two-point strategy, Quest Diagnostics has been focusing on areas with high potential. However, the reimbursement scenario remains a major cause of concern for thisZacks Rank #3 (Hold) company. Quest Diagnostics is currently focusing on diagnostic information services and disciplined capital deployment. Meanwhile, the company’s acquisitions and collaborations with hospitals and integrated delivery networks act as major growth drivers.
Companies facing a shortage of employees from health-care workers to forklift operators are confronting a new challenge: finding candidates who can pass drug tests in states that have legalized marijuana. Mentions Quest Drug Testing Index data.
According to Mayo Medical Laboratories' Jane Hermansen, "the best kept secret" at many of the hospitals she has observed over the course of her career is "the net revenue of their lab outreach programs." Quest in recent years has snapped up the outreach businesses of systems including Pacific Northwest-based PeaceHealth, Connecticut's Backus Hospital and the Hospital of Central Connecticut, and Flint, Michigan's Hurley Medical Center. LabCorp, meanwhile, has purchased businesses including Mount Sinai Clinical Outreach Laboratories, Spokane, Washington-based Pathology Associates Medical Laboratories, and Detroit Medical Center's outreach operation.
You see it in every major town and city. With 6,600 patient access points, Quest Diagnostics Incorporated (DGX) is one of the leading providers of patient diagnostics, laboratory testing, and genetic testing services in the United States. When you consider the importance of diagnostics in the medical field as well as testing services for a US labor force that faces pressure from drugs, Quest Diagnostics seems like a potentially lucrative investment opportunity.
Heightened awareness of the dangers of prescription opioids has prompted a movement to limit use of opioid therapies for patients with acute or chronic pain. Primary care practitioners stand on the front lines of this care shift, and many are curtailing prescribing opioids in response. But is the solution to the drug epidemic this straightforward? These latest data align with findings of an analysis of drug monitoring laboratory tests performed by Quest Diagnostics and published in the Journal of Addiction Medicine.
Quest Diagnostics Chairman, President, and Chief Executive Officer Steve Rusckowski led a group of dignitaries at a groundbreaking ceremony for a new flagship laboratory at the On3 campus earlier this month. With more than 1,100 employees expected to work at the new 250,000-square-foot facility when it opens in 2021, the lab, on the Clifton side of the ON3 campus redevelopment project, will be the company's largest.
The giant inflatable colon stolen from a Kansas City nonprofit last year will soon have a name. Quest Diagnostics and the Colon Cancer Coalition are hosting a naming ceremony Friday, March 1 at noon. Police said last year, thanks to a tip, officers found it in a vacant house near Virginia Avenue and Gregory Boulevard.
Roughly a year after its launch, a pilot project exploring the use of blockchain to manage healthcare provider records is paying off. The effort, which has thus far focused on some 100,000 provider locations across Texas, has produced substantial efficiencies for participating firms, said Jason O'Meara, senior director of architecture at Quest Diagnostics, one of the seven companies comprising the Synaptic Health Alliance, the healthcare industry group leading the project.
Quest Diagnostics said this week that its board has declared a quarterly cash dividend of $.53 per share, payable on April 22 to shareholders of record on April 8. Laboratory Corporation of America recorded net restructuring charges of $48.1 million related to severance and other personnel costs, and integration activities in 2018, it reported in its Form 10K to the US Securities and Exchange Commission this week.
Quest Diagnostics combined its chief information and digital officers into one role and named Gabrielle Wolfson, former Xerox Corp. CIO, to the role in February, according to The Wall Street Journal. Ms. Wolfson comes to Quest with experience managing the technology infrastructure and digital business at Xerox, according to the report. Former Quest Diagnostics CIO Lidia Fonseca left the role last year to take a position as chief digital officer at Pfizer.
Gov. Phil Murphy will reveal a state budget Tuesday that reduces spending on health care for New Jersey’s government workers by $800 million, alleviating at least some pressure on the state to hike major taxes this year, NJ Advance Media has learned. Murphy expects to save $61 million by auditing the insurance rolls and rooting out ineligible dependents, $7.9 million by auditing claims processed by the current pharmacy benefits manager, and $12.5 million by shifting Quest Diagnostics, the popular diagnostic lab, in network, among other changes, including rebidding the state’s contract for a pharmacy benefits manager.
Many of us remember the case of the missing giant inflatable colon. It was a mystery that kept Kansas City residents on the edge of their seats for a dozen days. With the #StolenColon hashtag going viral, many jokes and demands for answers were made all across social media. Now, with Friday marking the start of Colon Cancer Awareness Month, the stolon colon is back to work.
Quest Diagnostics said today it has entered a partnership agreement with Regional Medical Center of Orangeburg, South Carolina.[CR-LF][CR-LF]Under the agreement, Quest will provide RMC with full laboratory management services, including management, equipment, reference testing, supplies, and procurement services.